Novel therapeutics in adult malignant brain gliomas

Author： Reni Michele Mazza Elena Tosoni Alicia Brandes Alba A

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.6, 2005-06, pp. : 643-658

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Radiotherapy for Malignant Gliomas

Current Drug Discovery Technologies, Vol. 9, Iss. 4, 2012-01 ,pp. : 268-279

Bentham Science Publishers

Access to resources Recommend Favorite

The Blood-Brain/Tumor Barriers: Challenges and Chances for Malignant Gliomas Targeted Drug Delivery

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 12, 2012-09 ,pp. : 2380-2387

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 840-848

Bentham Science Publishers

Access to resources Recommend Favorite

Brain Slices as Models for Neurodegenerative Disease and Screening Platforms to Identify Novel Therapeutics

Current Neuropharmacology, Vol. 5, Iss. 1, 2007-01 ,pp. : 19-33

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic Approaches to Malignant Gliomas

Current Cancer Drug Targets, Vol. 12, Iss. 3, 2012-01 ,pp. : 279-288

Bentham Science Publishers

Access to resources Recommend Favorite